1. Recurrent Angina: New Tools for an Old Problem

2. Angina in the United States: Morbidity and Age-Related Issues

3. Nonflow-Limiting Lesions Are the Principal Progenitors of Most Acute MI Events

4. Meta-analysis of PCI vs Medical Therapy Trials: Death and Nonfatal MI Outcomes

5. Chronic Stable Coronary Artery Disease Performance Measurement Set

6. 75-Year-Old Woman With T2DM

7. 75-Year-Old Woman (cont)

8. 75-Year-Old Woman (cont): Medications

9. Reductions in A1c Seen With Ranolazine Use in Randomized Trials

10. 53-Year-Old Woman

11. 53-Year-Old Woman (cont)

12. 53-Year-Old Woman (cont): Family History

14. 53-Year-Old Woman (cont): Medications and Lab Results

15. 53-Year-Old Woman (cont): Clinical Decision Point

16. Microvascular Coronary Dysfunction in Women With Angina and Ischemia, but no Obstructive CAD

17. WISE: 5-Year Rates of CV Outcomes in Symptomatic Women With No CAD vs Nonobstructive CAD

18. Nonobstructive CAD and All-Cause Mortality

19. Plan of Care for Chronic Stable Coronary Artery Disease

20. 53-Year-Old Woman (cont): Clinical Decision Point

21. DASI: Measures Functional Capacity and Assesses Aspects of Quality of Life

22. Program Summary

23. Abbreviations

24. Abbreviations